NETMEDIX Trademark

Trademark Overview

On Monday, September 26, 2016, a trademark application was filed for NETMEDIX with the United States Patent and Trademark Office. The USPTO has given the NETMEDIX trademark a serial number of 87183580. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, April 23, 2019. This trademark is owned by RadioMedix, Inc.. The NETMEDIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product, namely, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients
netmedix

General Information

Serial Number87183580
Word MarkNETMEDIX
Filing DateMonday, September 26, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, April 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical product, namely, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, April 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRadioMedix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77042
Party NameRadioMedix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77042

Trademark Events

Event DateEvent Description
Tuesday, April 23, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, April 23, 2019ABANDONMENT - AFTER PUBLICATION
Monday, April 22, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Friday, February 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 20, 2018EXTENSION 3 GRANTED
Thursday, September 20, 2018EXTENSION 3 FILED
Thursday, September 20, 2018TEAS EXTENSION RECEIVED
Wednesday, April 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 16, 2018EXTENSION 2 GRANTED
Monday, April 16, 2018EXTENSION 2 FILED
Monday, April 16, 2018TEAS EXTENSION RECEIVED
Wednesday, August 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2017EXTENSION 1 GRANTED
Monday, July 31, 2017EXTENSION 1 FILED
Monday, July 31, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 17, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, January 17, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 17, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, January 17, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, January 2, 2017ASSIGNED TO EXAMINER
Thursday, September 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

netmedix neuroendocrine tumors pharmaceutical cancer patients management localization diagnostic targeted detection